A Study With ASP2151 in Subjects With Recurrent Episodes of Genital Herpes
Public ClinicalTrials.gov record NCT00486200. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Dose-Finding Study With ASP2151 in Subjects With Recurrent Episodes of Genital HErpes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.
Study identification
- NCT ID
- NCT00486200
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 695 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 20, 2007
- Primary completion
- Aug 11, 2008
- Completion
- Aug 11, 2008
- Last update posted
- Dec 6, 2017
2007 – 2008
United States locations
- U.S. sites
- 25
- U.S. states
- 18
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Phoenix | Arizona | 85015 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Los Angeles | California | 90017 | — |
| Not listed | Sacramento | California | 95821 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | Westlake Village | California | 91361 | — |
| Not listed | Denver | Colorado | 80262 | — |
| Not listed | Boynton Beach | Florida | 33472 | — |
| Not listed | Miami | Florida | 33156 | — |
| Not listed | Atlanta | Georgia | 30328 | — |
| Not listed | Indianapolis | Indiana | 46202 | — |
| Not listed | Madisonville | Kentucky | 42431 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Billings | Montana | 59101 | — |
| Not listed | Omaha | Nebraska | 68134 | — |
| Not listed | Albuquerque | New Mexico | 87131 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Philadelphia | Pennsylvania | 19103 | — |
| Not listed | Arlington | Texas | 76011 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Houston | Texas | 77058 | — |
| Not listed | Salt Lake City | Utah | 84132 | — |
| Not listed | Annandale | Virginia | 22003 | — |
| Not listed | Seattle | Washington | 98122 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00486200, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2017 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00486200 live on ClinicalTrials.gov.